Prognostication Using SCORTEN Severity of Illness Score in Patients With Stevens Johnson Syndrome and Toxic Epidermal Necrolysis.

J Pain Symptom Manage

Division of Geriatrics and Palliative Care, Department of Family and Community Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Published: January 2019

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpainsymman.2018.09.019DOI Listing

Publication Analysis

Top Keywords

prognostication scorten
4
scorten severity
4
severity illness
4
illness score
4
score patients
4
patients stevens
4
stevens johnson
4
johnson syndrome
4
syndrome toxic
4
toxic epidermal
4

Similar Publications

Article Synopsis
  • Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious skin reactions with high in-hospital mortality rates, ranging from 12-49%, prompting a need for better mortality prognostication.
  • This systematic review and meta-analysis examined factors that could predict mortality in SJS and TEN patients, focusing on predictors not included in the widely used SCORTEN scoring system.
  • The study found that conditions like preexisting renal disease, renal and respiratory involvement, diabetes, sepsis, comorbidity, and delayed hospitalization significantly increased the risk of death in these patients, providing valuable insights for clinical assessment.
View Article and Find Full Text PDF
Article Synopsis
  • Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are serious skin reactions mainly triggered by drugs, and SCORTEN is used to predict their severity and mortality risk.
  • A recent study sought to determine if the neutrophil-lymphocyte ratio (NLR) could serve as a prognostic marker for SJS/TEN by analyzing patient data over four years from a hospital.
  • Although a weak positive correlation was found between NLR and SCORTEN, it wasn’t statistically significant, suggesting that while NLR indicates systemic inflammation, its effectiveness in predicting disease severity needs further research with more patients.
View Article and Find Full Text PDF

Inflammatory markers such as neutrophil-lymphocyte ratio (NLR) and eosinophil count are known prognostic indicators for the severity of Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). This study explores the correlation of systemic immune-inflammation index (SII), platelet-lymphocyte ratio (PLR) and NLR with Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN) and patient outcomes. A retrospective audit of 34 patients with SJS/TEN (25 SJS, 3 SJS/TEN overlap, 6 TEN) was conducted from 2018 to 2022.

View Article and Find Full Text PDF

Background: Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are life-threatening dermatological emergencies. SCORTEN (SCORe of toxic epidermal necrolysis) is a validated score to predict mortality; however, there is a paucity of data to determine its usefulness in the Indian population.

Objective: To evaluate the accuracy of SCORTEN as a prognostic marker in SJS-TEN.

View Article and Find Full Text PDF

RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.

Allergy Asthma Immunol Res

November 2023

The Institute of Dermatology and Venereology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, China.

Purpose: Our study aimed to explore potential prognostic factors in Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) patients from easily accessible laboratory data and to investigate whether the combination of these indicators with a score for toxic epidermal necrolysis (SCORTEN) can improve the predictive value.

Methods: Data from 85 SJS/TEN patients hospitalized from 2010 to 2021 were retrospectively analyzed. The primary outcome was in-hospital mortality.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!